U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07501845) titled 'Registry Maastro Applicator' on March 12.
Brief Summary: This registry will collect data from all patients treated with the MAASTRO HDR applicator. The goal is to deepen knowledge about dose-response relationships in rectal cancer boosting, which is essential for improving future treatment approaches and patient selection.
Study Start Date: March 15
Study Type: OBSERVATIONAL
Condition:
Rectal Cancer
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Maastricht Radiation Oncology
Published by HT Digital Content Services with permission from Health Daily Digest....